Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Intro to Bioniche
View:
Post by DamnYankees on Sep 17, 2014 8:06pm

Intro to Bioniche

I have a few questions for the regular followers. New and thinking of taking a position:

1. Is there any anlyst or banking coverage on the stock today? Are there any reports available because there isn't much independent info available on line at all?

2. Is the cash position 10 mil canadian or 18 mil canadian? I have found both numbers at various sources today and I know a financing is being worked on so I am looking at after financing cash.

3. Is a second Phase 3 trial required or is that to be determined? It sounds like it is not but that is not clear when researching.

4. Is the product licensed in Canada? Has it been turned down or not applied for yet?

5. Is Endo still the US partner?

6. Weird question, but what are the reasons for a 25 million dollar total valuation? The company just looks missed under the radar unless I am missing something.

TIA
Comment by beechguy on Sep 17, 2014 9:01pm
There is no analyst coverage that I know of except for Sujan Lahiri's from seeking alpha today. As far as I know there is just over 15mm in cash after the financing. Burn is around 700k month. There doesn't have to be a phase 3b according to the FDA. We are waiting to find out if we get orphan status (one month) and special protocol (we find out upon submission Q1 calendar 2015) We are in ...more  
Comment by Tson99 on Sep 23, 2014 11:06am
Hey Beech, you said, "We are in the midst of applying to health Canada but since the FDA decision they have decided to wait for FDA before they proceed with Canada." Is this something you heard from Bioniche? I don't remember seeing that anounced anywhere, maybe I missed it. Cheers, Tson99
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities